Compare JUBILANT LIFE SCIENCES with SUVEN LIFE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs SUVEN LIFESCIENCES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES SUVEN LIFESCIENCES JUBILANT LIFE SCIENCES/
SUVEN LIFESCIENCES
 
P/E (TTM) x 14.9 19.9 74.9% View Chart
P/BV x 1.7 4.0 43.2% View Chart
Dividend Yield % 0.9 0.5 163.8%  

Financials

 JUBILANT LIFE SCIENCES   SUVEN LIFESCIENCES
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-19
SUVEN LIFESCIENCES
Mar-19
JUBILANT LIFE SCIENCES/
SUVEN LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs898338 265.9%   
Low Rs618169 364.5%   
Sales per share (Unadj.) Rs572.052.1 1,097.3%  
Earnings per share (Unadj.) Rs36.26.8 530.3%  
Cash flow per share (Unadj.) Rs59.58.6 694.4%  
Dividends per share (Unadj.) Rs4.501.50 300.0%  
Dividend yield (eoy) %0.60.6 100.4%  
Book value per share (Unadj.) Rs301.965.3 462.4%  
Shares outstanding (eoy) m159.28127.28 125.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.34.9 27.2%   
Avg P/E ratio x20.937.1 56.4%  
P/CF ratio (eoy) x12.729.6 43.0%  
Price / Book Value ratio x2.53.9 64.6%  
Dividend payout %12.422.0 56.6%   
Avg Mkt Cap Rs m120,69432,272 374.0%   
No. of employees `0002.41.1 220.9%   
Total wages/salary Rs m19,260661 2,912.8%   
Avg. sales/employee Rs Th38,120.66,132.2 621.6%   
Avg. wages/employee Rs Th8,058.4611.1 1,318.7%   
Avg. net profit/employee Rs Th2,414.3803.5 300.5%   
INCOME DATA
Net Sales Rs m91,1086,635 1,373.1%  
Other income Rs m357242 147.5%   
Total revenues Rs m91,4666,877 1,330.0%   
Gross profit Rs m17,3901,604 1,084.0%  
Depreciation Rs m3,709221 1,675.2%   
Interest Rs m2,19838 5,830.5%   
Profit before tax Rs m11,8401,587 745.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-2,8020-   
Tax Rs m3,268718 455.2%   
Profit after tax Rs m5,770869 663.7%  
Gross profit margin %19.124.2 78.9%  
Effective tax rate %27.645.2 61.0%   
Net profit margin %6.313.1 48.3%  
BALANCE SHEET DATA
Current assets Rs m45,8486,232 735.7%   
Current liabilities Rs m20,8971,490 1,402.4%   
Net working cap to sales %27.471.5 38.3%  
Current ratio x2.24.2 52.5%  
Inventory Days Days5786 65.7%  
Debtors Days Days5183 61.7%  
Net fixed assets Rs m65,4984,043 1,619.9%   
Share capital Rs m159127 125.1%   
"Free" reserves Rs m47,9308,183 585.7%   
Net worth Rs m48,0898,310 578.7%   
Long term debt Rs m42,42918 238,364.6%   
Total assets Rs m114,68510,389 1,103.9%  
Interest coverage x6.443.1 14.8%   
Debt to equity ratio x0.90 41,189.8%  
Sales to assets ratio x0.80.6 124.4%   
Return on assets %6.98.7 79.6%  
Return on equity %12.010.5 114.7%  
Return on capital %12.419.5 63.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m12,4225,622 221.0%   
Fx outflow Rs m17,2271,799 957.4%   
Net fx Rs m-4,8053,822 -125.7%   
CASH FLOW
From Operations Rs m11,215356 3,154.7%  
From Investments Rs m-10,118-279 3,631.9%  
From Financial Activity Rs m6,574-225 -2,920.6%  
Net Cashflow Rs m7,612-148 -5,136.4%  

Share Holding

Indian Promoters % 45.6 63.4 71.9%  
Foreign collaborators % 3.5 0.0 -  
Indian inst/Mut Fund % 8.7 0.0 -  
FIIs % 21.2 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 36.5 57.8%  
Shareholders   23,815 37,287 63.9%  
Pledged promoter(s) holding % 15.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   ELDER PHARMA  FDC LTD.  SHASUN PHARMA  DISHMAN PHARMA  TTK HEALTHCARE  

Compare JUBILANT LIFE SCIENCES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Lower; Metal and Banking Stocks Drag(09:30 am)

Asian share markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 1% while the Hang Seng is up 1.1%.

Related Views on News

JUBILANT LIFE SCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (1QFY20); Net Profit Down 7.7% (Quarterly Result Update)

Jul 29, 2019 | Updated on Jul 29, 2019

For the quarter ended June 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (down 7.7% YoY). Sales on the other hand came in at Rs 22 bn (up 5.0% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Sep 19, 2019 11:35 AM

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 8-QTR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS